The Risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers

Hilary D. Hinshaw, Ashlee Smith, Bunja Rungruang, Joseph L. Kelley, Sushil Beriwal, Thomas C. Krivak, Paniti Sukumvanich, Alexander B. Olawaiye

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Type II endometrial cancers include uterine papillary serous carcinoma (UPSC) and clear cell endometrial cancer (CC). Given their relative rarity, aggressive nature, and poor prognosis, little is known about the risk of subsequent malignancies at other sites. Our objective was to determine if women with UPSC or CC are at increased risk of subsequent malignancies. Methods: Women diagnosed with UPSC or CC were identified from the SEER (Surveillance Epidemiology and End Results) Program from 1973 to 2005. Cases with a second gynecologic malignancy were excluded. Using SEER * Stat software, standardized incidence ratios (SIRs) of subsequent malignancies were calculated. Results: A total of 8045 and 1740 patientswere diagnosed with UPSC and CC, respectively. Four hundred sixty-one (5.7%) of the UPSC cases were diagnosed with at least 1 additional nongynecologic malignancy. Significant associations were found with the following malignancies: the renal pelvis, soft-tissue sarcomas, acutemyeloid leukemia, the bladder, and colon. Seventy-eight CC cases (4.5%) were diagnosed with at least 1 additional malignancy. In comparison with the baseline population risk, there was no statistically significant increased risk of any subsequent malignancy with a primary diagnosis of CC. Conclusions: This is the first large population-based analysis of second primary malignancies after type II endometrial cancers. Uterine papillary serous carcinoma is associated with increased risks of certain subsequent malignancies, and providers should be aware of these when following up patients with this diagnosis, especially those with stage I disease. In contrast, no such associations were found with CC in this cohort.

Original languageEnglish (US)
Pages (from-to)1044-1049
Number of pages6
JournalInternational Journal of Gynecological Cancer
Volume23
Issue number6
DOIs
StatePublished - Jul 1 2013

Fingerprint

Endometrial Neoplasms
Papillary Carcinoma
Neoplasms
Second Primary Neoplasms
SEER Program
Kidney Pelvis
Sarcoma
Population
Colon
Leukemia
Epidemiology
Urinary Bladder
Software

Keywords

  • Clear cell endometrial cancer
  • Subsequent malignancies
  • Type II endometrial cancer
  • Uterine papillary serous carcinoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

The Risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers. / Hinshaw, Hilary D.; Smith, Ashlee; Rungruang, Bunja; Kelley, Joseph L.; Beriwal, Sushil; Krivak, Thomas C.; Sukumvanich, Paniti; Olawaiye, Alexander B.

In: International Journal of Gynecological Cancer, Vol. 23, No. 6, 01.07.2013, p. 1044-1049.

Research output: Contribution to journalArticle

Hinshaw, Hilary D. ; Smith, Ashlee ; Rungruang, Bunja ; Kelley, Joseph L. ; Beriwal, Sushil ; Krivak, Thomas C. ; Sukumvanich, Paniti ; Olawaiye, Alexander B. / The Risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers. In: International Journal of Gynecological Cancer. 2013 ; Vol. 23, No. 6. pp. 1044-1049.
@article{b6b1d40c8c884bc889ac95a12e5ba508,
title = "The Risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers",
abstract = "Objective: Type II endometrial cancers include uterine papillary serous carcinoma (UPSC) and clear cell endometrial cancer (CC). Given their relative rarity, aggressive nature, and poor prognosis, little is known about the risk of subsequent malignancies at other sites. Our objective was to determine if women with UPSC or CC are at increased risk of subsequent malignancies. Methods: Women diagnosed with UPSC or CC were identified from the SEER (Surveillance Epidemiology and End Results) Program from 1973 to 2005. Cases with a second gynecologic malignancy were excluded. Using SEER * Stat software, standardized incidence ratios (SIRs) of subsequent malignancies were calculated. Results: A total of 8045 and 1740 patientswere diagnosed with UPSC and CC, respectively. Four hundred sixty-one (5.7{\%}) of the UPSC cases were diagnosed with at least 1 additional nongynecologic malignancy. Significant associations were found with the following malignancies: the renal pelvis, soft-tissue sarcomas, acutemyeloid leukemia, the bladder, and colon. Seventy-eight CC cases (4.5{\%}) were diagnosed with at least 1 additional malignancy. In comparison with the baseline population risk, there was no statistically significant increased risk of any subsequent malignancy with a primary diagnosis of CC. Conclusions: This is the first large population-based analysis of second primary malignancies after type II endometrial cancers. Uterine papillary serous carcinoma is associated with increased risks of certain subsequent malignancies, and providers should be aware of these when following up patients with this diagnosis, especially those with stage I disease. In contrast, no such associations were found with CC in this cohort.",
keywords = "Clear cell endometrial cancer, Subsequent malignancies, Type II endometrial cancer, Uterine papillary serous carcinoma",
author = "Hinshaw, {Hilary D.} and Ashlee Smith and Bunja Rungruang and Kelley, {Joseph L.} and Sushil Beriwal and Krivak, {Thomas C.} and Paniti Sukumvanich and Olawaiye, {Alexander B.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1097/IGC.0b013e3182959053",
language = "English (US)",
volume = "23",
pages = "1044--1049",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The Risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers

AU - Hinshaw, Hilary D.

AU - Smith, Ashlee

AU - Rungruang, Bunja

AU - Kelley, Joseph L.

AU - Beriwal, Sushil

AU - Krivak, Thomas C.

AU - Sukumvanich, Paniti

AU - Olawaiye, Alexander B.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Objective: Type II endometrial cancers include uterine papillary serous carcinoma (UPSC) and clear cell endometrial cancer (CC). Given their relative rarity, aggressive nature, and poor prognosis, little is known about the risk of subsequent malignancies at other sites. Our objective was to determine if women with UPSC or CC are at increased risk of subsequent malignancies. Methods: Women diagnosed with UPSC or CC were identified from the SEER (Surveillance Epidemiology and End Results) Program from 1973 to 2005. Cases with a second gynecologic malignancy were excluded. Using SEER * Stat software, standardized incidence ratios (SIRs) of subsequent malignancies were calculated. Results: A total of 8045 and 1740 patientswere diagnosed with UPSC and CC, respectively. Four hundred sixty-one (5.7%) of the UPSC cases were diagnosed with at least 1 additional nongynecologic malignancy. Significant associations were found with the following malignancies: the renal pelvis, soft-tissue sarcomas, acutemyeloid leukemia, the bladder, and colon. Seventy-eight CC cases (4.5%) were diagnosed with at least 1 additional malignancy. In comparison with the baseline population risk, there was no statistically significant increased risk of any subsequent malignancy with a primary diagnosis of CC. Conclusions: This is the first large population-based analysis of second primary malignancies after type II endometrial cancers. Uterine papillary serous carcinoma is associated with increased risks of certain subsequent malignancies, and providers should be aware of these when following up patients with this diagnosis, especially those with stage I disease. In contrast, no such associations were found with CC in this cohort.

AB - Objective: Type II endometrial cancers include uterine papillary serous carcinoma (UPSC) and clear cell endometrial cancer (CC). Given their relative rarity, aggressive nature, and poor prognosis, little is known about the risk of subsequent malignancies at other sites. Our objective was to determine if women with UPSC or CC are at increased risk of subsequent malignancies. Methods: Women diagnosed with UPSC or CC were identified from the SEER (Surveillance Epidemiology and End Results) Program from 1973 to 2005. Cases with a second gynecologic malignancy were excluded. Using SEER * Stat software, standardized incidence ratios (SIRs) of subsequent malignancies were calculated. Results: A total of 8045 and 1740 patientswere diagnosed with UPSC and CC, respectively. Four hundred sixty-one (5.7%) of the UPSC cases were diagnosed with at least 1 additional nongynecologic malignancy. Significant associations were found with the following malignancies: the renal pelvis, soft-tissue sarcomas, acutemyeloid leukemia, the bladder, and colon. Seventy-eight CC cases (4.5%) were diagnosed with at least 1 additional malignancy. In comparison with the baseline population risk, there was no statistically significant increased risk of any subsequent malignancy with a primary diagnosis of CC. Conclusions: This is the first large population-based analysis of second primary malignancies after type II endometrial cancers. Uterine papillary serous carcinoma is associated with increased risks of certain subsequent malignancies, and providers should be aware of these when following up patients with this diagnosis, especially those with stage I disease. In contrast, no such associations were found with CC in this cohort.

KW - Clear cell endometrial cancer

KW - Subsequent malignancies

KW - Type II endometrial cancer

KW - Uterine papillary serous carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84880311758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880311758&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e3182959053

DO - 10.1097/IGC.0b013e3182959053

M3 - Article

C2 - 23748174

AN - SCOPUS:84880311758

VL - 23

SP - 1044

EP - 1049

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 6

ER -